Ionis Pharmaceuticals Upgraded to Buy What Does It Mean for the Stock?
| IONS Stock | USD 38.26 0.32 0.83% |
Slightly above 55% of Ionis Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Ionis Pharmaceuticals suggests that many traders are impartial. Ionis Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Ionis Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Ionis |
Ionis Pharmaceuticals might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 .
Read at zacks.com
 |
Ionis Pharmaceuticals Current Investor Sentiment
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ionis Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ionis Pharmaceuticals.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Ionis Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ionis Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ionis Pharmaceuticals Fundamental Analysis
We analyze Ionis Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ionis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ionis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Ionis Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Ionis Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ionis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Ionis Pharmaceuticals Related Equities
| TERN | Terns Pharmaceuticals | 5.17 | ||||
| PTCT | PTC Therapeutics | 4.02 | ||||
| ARWR | Arrowhead Pharmaceuticals | 2.79 | ||||
| HALO | Halozyme Therapeutics | 1.36 | ||||
| KRYS | Krystal Biotech | 0.73 | ||||
| INCY | Incyte | 0.51 | ||||
| EXEL | Exelixis | 0.17 | ||||
| BMRN | Biomarin Pharmaceutical | 0.57 | ||||
| ALNY | Alnylam Pharmaceuticals | 0.77 | ||||
| APLS | Apellis Pharmaceuticals | 1.09 | ||||
| AKRO | Akero Therapeutics | 1.54 | ||||
| MDGL | Madrigal Pharmaceuticals | 1.78 | ||||
| SRPT | Sarepta Therapeutics | 1.78 | ||||
| IOVA | Iovance Biotherapeutics | 3.91 | ||||
| VKTX | Viking Therapeutics | 4.97 |
Additional Tools for Ionis Stock Analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.